Full-Face Carbon Dioxide Laser Resurfacing in the Management of a Patient with the Nevoid Basal Cell Carcinoma Syndrome

Dermatologic Surgery

Volumn 29, Issue 12, 2003, Pages 1236-1240

  Doctoroff, Alexander ^a   Oberlender, Steven A ^a   Purcell, Stephen M ^a,b  

^a PHILADELPHIA COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

^b Advanced Dermatology Associates ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMIQUIMOD;

ADULT; ARTICLE; BASAL CELL NEVUS SYNDROME; CANCER PATIENT; CANCER RECURRENCE; CANCER SURGERY; CARBON DIOXIDE LASER; CASE REPORT; CHEMOSURGERY; CLINICAL FEATURE; CREAM; CURETTAGE; DISEASE COURSE; DRUG FORMULATION; FEMALE; HUMAN; LASER SURGERY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SKIN SURFACE; TREATMENT OUTCOME; ULTRAVIOLET RADIATION;

ADULT; BASAL CELL NEVUS SYNDROME; CARBON DIOXIDE; FEMALE; HUMANS; LASER SURGERY; SKIN NEOPLASMS;

EID: 0348147674     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2003.29395.x     Document Type: Article

References (22)

1. Halpern AC, Altman JF. Genetic predisposition to skin cancer. Curr Opin Oncol 1999;11:132-42.
2. Kimonis VE, Goldstein AM, Pastakia B, et al. Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome. Am J Med Genet 1997;69:299-308.
3. El Sobky R, Kallab AM, Dainer PM, Jillella AP, Lesher JL. Successful treatment of an intractable case of hereditary basal cell carcinoma syndrome with paclitaxel. Arch Dermatol 2001;137:827-8.
4. Rifkin R, Reed B, Hetzel F, Chen K. Photodynamic therapy using SnET2 for basal cell nevus syndrome: a case report. Clin Ther 1997;19:639-41.
5. Tsuji T, Otake N, Nishimura M. Cryosurgery and topical fluorouracil: a treatment method for widespread basal cell epithelioma in basal cell nevus syndrome. J Dermatol 1993;20:507-13.
6. Kagy MK, Amonette R. The use of imiquimod 5% cream for the treatment of superficial basal cell carcinomas in a basal cell nevus syndrome patient. Dermatol Surg 2000;26:577-8.
7. Adams EL, Price NM. Treatment of basal-cell carcinomas with a carbon-dioxide laser. J Dermatol Surg Oncol 1979;5:803-6.
8. Wheeland RG, Bailin PL, Roenigk RK. Carbon dioxide laser vaporization and curettage in the treatment of large or multiple superficial basal cell carcinomas. J Dermatol Surg Oncol 1987;13:119-25.
9. Krunic AL, Viehman GE, Madani S, Clark RE. Microscopically controlled surgical excision combined with ultrapulse CO2 vaporization in the management of a patient with the nevoid basal cell carcinoma syndrome. J Dermatol 1998;25:10-2.
10. Grobbelaar AO, Horlock N. Gorlin syndrome: the role of the carbon dioxide laser in patient management. Ann Plast Surg 1997;39:366-73.
11. Nouri K, Chang A, Trent JT, Jimenez GP. Ultrapulse CO2 used for the successful treatment of basal cell carcinomas found in patients with basal cell nevus syndrome. Dermatol Surg 2002;3:287-90.
12. Kopera D, Cerroni L, Fink-Puches R, Kerl H. Different treatment modalities for the management of a patient with the nevoid basal cell carcinoma syndrome. J Am Acad Dermatol 1996;34:937-9.
13. Sanchez-Conejo-Mir J, Camacho F. Nevoid basal cell carcinoma syndrome: combined etretinate and surgical treatment. J Dermatol Surg Oncol 1989;15:868-71.
14. Sollitto RB, DiGiovanna JJ. Failure of interferon alfa and isotretinoin combination therapy in the nevoid basal cell carcinoma syndrome. Arch Dermatol 1996;132:94-5.
15. Peck GL, DiGiovanna JJ, Sarnoff DS, et al. Treatment and prevention of basal cell carcinoma with oral isotretinoin. J Am Acad Dermatol 1988;19:176-85.
16. Peck GL, Gross EG, Butkus D, DiGiovanna JJ. Chemoprevention of basal cell carcinoma with isotretinoin. J Am Acad Dermatol 1982;6:815-23.
17. Peck GL. Long-term retinoid therapy is needed for maintenance of cancer chemopreventive effect. Dermatologica 1987;175:138-44.
18. Crisofolini M, Zumiani G, Scappini P, Piscioli F. Aromatic retinoid in the chemoprevention of the progression of nevoid basal cell carcinoma syndrome. J Derm Surg Oncol 1984;10:778-81.
19. Hodak E, Ginzburg A, David M, Sandbank M. Etretinate treatment of the nevoid basal cell carcinoma syndrome: therapeutic and chemopreventive effect. Int J Dermatol 1987;26:606-9.
20. DiGiovanna JJ. Retinoid chemoprevention in the high-risk patient. J Am Acad Dermatol 1998;39(2 Pt 3):S82-5.
21. Vanderveen EE, Grekin RC, Swanson NA, Kragballe K. Arachidonic acid metabolites in cutaneous carcinoma: evidence suggesting that elevated levels of prostaglandins in basal cell carcinomas are associated with an aggressive growth pattern. Arch Dermatol 1986;122:407-12.
22. Bickers DR, Athar M. Novel approaches to chemoprevention of skin cancer. J Dermatol 2000;27:691-5.